切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - ERK - Peptidylprolyl isomerases

14件产品中的 1-10

页面
每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. VRT752271
    B1106 VRT752271
    Target: ERK
    Summary: ERK1/ERK2 inhibitor
      ≥43.3 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Tacrolimus (FK506)
    B2143 Tacrolimus (FK506)
     2 Citation
    中文名: 他克莫司
    Target: Peptidylprolyl isomerases
    Summary: 大环内酯类钙调神经磷酸酶抑制剂,免疫抑制剂。
      ≥26.6 mg/mL
      insoluble in H2O
  7. A-674563
    A8616 A-674563
    Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK
    Summary: Akt1 / PKA / CDK2的强效选择性抑制剂
      ≥4.9 mg/mL
      ≥23.8 mg/mL
  8. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  9. FR 180204
    A8304 FR 180204
    Target: ERK
    Summary: ERK inhibitor
      ≥10.25 mg/mL
      insoluble in H2O
  10. BIX 02189
    A5801 BIX 02189
    Target: MEK|ERK
    Summary: MEK5抑制剂
      ≥22.05 mg/mL
      insoluble in H2O

14件产品中的 1-10

页面
每页